Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Across the Phase 3 TRIUMPH-2 and TRIUMPH-3 trials, Lillys investigational triple agonist delivered up to 22.6% mean weight loss at 80 weeks, alongside robust glycaemic improvement and broad cardiometabolic risk-factor reductions
Their consensus
and GHRP-2, a strong growth hormone secretagogue
By targeting both pathways, tirzepatide offers a dual-action mechanism that reduces appetite and improves insulin sensitivity
10.1097/01.jnen.0000202887.22082.63 J
In some cases, your doctor might prescribe a GLP-1 receptor agonist if you have obesity
US$ 21.83
US$ 28.82
US$ 21.32
US$ 27.61
US$ 22.16
US$ 25.99
:max_bytes(150000):strip_icc()/insulin-injection-478185779-594b3cae3df78cae8111498f.jpg)
